Funder
National Natural Science Foundation of China
Personnel training special funds of the Second Affiliated Hospital of Xi’an Jiaotong University
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Infectious Diseases,Oncology,Epidemiology
Reference42 articles.
1. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology, Chinese Medical Association. Guidelines of prevention and treatment for hepatitis C. Zhonghua Gan Zang Bing Za Zhi. 2015;23:906–23.
2. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553–62.
3. Fusco M, Piselli P, Virdone S, Di Cicco P, Scognamiglio P, De Paoli P, et al. Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study. Infect Agent Cancer. 2016;11:54.
4. Durham DP, Skrip LA, Bruce RD, Vilarinho S, Elbasha EH, Galvani AP, et al. The impact of enhanced screening and treatment on hepatitis C in the United States. Clin Infect Dis. 2016;62:298–304.
5. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138:513–21. 521. e1-6